Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration

Usha Acharya, Shetal Patel, Edmund Koundakjian, Kunio Nagashima, Xianlin Han, Jairaj K. Acharya

Research output: Contribution to journalArticle

105 Scopus citations

Abstract

Mutations in proteins of the Drosophila phototransduction cascade, a prototypic guanine nucleotide-binding protein-coupled receptor signaling system, lead to retinal degeneration and have been used as models to understand human degenerative disorders. Here, modulating the sphingolipid biosynthetic pathway rescued retinal degeneration in Drosophila mutants. Targeted expression of Drosophila neutral ceramidase rescued retinal degeneration in arrestin and phospholipase C mutants. Decreasing flux through the de novo sphingolipid biosynthetic pathway also suppressed degeneration in these mutants, Both genetic backgrounds modulated the endocytic machinery because they suppressed defects in a dynamin mutant. Suppression of degeneration in arrestin mutant flies expressing ceramidase correlated with a decrease in ceramide levels. Thus, enzymes of sphingolipid metabolism may be suitable targets in the therapeutic management of retinal degeneration.

Original languageEnglish (US)
Pages (from-to)1740-1743
Number of pages4
JournalScience
Volume299
Issue number5613
DOIs
StatePublished - Mar 14 2003

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this

Acharya, U., Patel, S., Koundakjian, E., Nagashima, K., Han, X., & Acharya, J. K. (2003). Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science, 299(5613), 1740-1743. https://doi.org/10.1126/science.1080549